WHO vaccine-preventable diseases: monitoring system. 2015 global summary

Last updated 15-Jul-2015 (Data received as of 10-Jul-2015)
Next overall update Fall 2015
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 7'3801 Infant (under 12 months) mortality rate: 122
GDP / capita (US$): 13'2171 Child (under 5 years) mortality rate: 142

Population data in thousands3

  2014  2013  2012  2011  2010  2000  1990  1980 
Total population 1'393'784  1'385'567  1'377'065  1'368'440  1'359'821  1'280'429  1'165'429  984'016 
Births 18'330  18'440  18'455  18'375  18'204  16'111  26'447  21'018 
Surviving infants 18'105  18'203  18'203  18'108  17'920  15'719  25'601  20'184 
Pop. less than 5 years 90'993  90'187  88'934  87'400  85'579  83'372  136'835  98'790 
Pop. less than 15 years 252'281  249'829  247'738  246'604  246'707  327'734  341'465  348'344 
Female 15-49 years 368'974  372'548  375'435  377'356  378'179  347'573  306'018  232'603 

Number of reported case

(Click for retrospective incidence data for China)
Diphtheria 19  421  9'767 
Japanese encephalitis 858  2'178  1'763  1'625  2'541 
Measles 52'628  26'883  6'183  9'943  38'159  71'093  85'705  1'122'285 
Mumps 187'500  327'759  479'518  454'385  298'932 
Pertussis 3'408  1'712  2'183  2'517  1'764  5'561  20'015  613'648 
Polio* 21  5'065  7'442 
Rubella 11'793  17'580  40'156  65'549  43'117 
Rubella (CRS)
Tetanus (neonatal) 426  492  674  1'057  3'230 
Tetanus (total)** 426  492 
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For desagregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for China)
Vaccine year result method % card seen                                                
BCG 2007  99  HHS     99  99*  99  99*  99  85  99 
DTP1          99  99*  99  99*  99 
DTP3 2007  91  HHS     99  99*  99  99*  99  85  97 
DTP4          99 
IPV1         
HepB_BD          94  99  96  95  92 
HepB3 2007  93  HHS     99  99*  99  99*  99  60 
Hib3         
JapEnc          99  99*  99  99  99 
MCV1          99  99*  99  99*  99  98  98 
MCV2          99  99*  99  99  99 
PCV1         
PCV3         
Pol3 2007  92  HHS     99  99*  99  99*  99  90  98 
Rota1         
Rota_last         
Rubella1          99  96  99  99  96 
TT2plus         
PAB         
VAD1         
YFV         
  ° indicates that more than 1 survey occurred that year

  Next update: Mid July 2016

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for China)
BCG 99  99  99  99  99  84  99 
DTP1 99  99  99  99  99  94  98 
DTP3 99  99  99  99  99  85  97 
HepB3 99  99  99  99  99  60 
HepB_BD 94  99  96  95  92 
Hib3
MCV1 99  99  99  99  99  84  98 
MCV2 99  99  99  99  99 
PCV3
Pol3 99  99  99  99  99  86  98 
Rota_last

Number of districts in the country 2'959  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
99 
   
/
|
|
\
Greater or equal to 90% 85
From 80 to 89% 6
From 50 to 79% 4
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
5
 

Immunization Schedule (2014 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DT 6 years; Yes
DTaP 3, 4, 5, 18-24 (x2) months; Yes
HepA 18 months; Yes
HepB birth; 1, 6 months; Yes
Influenza_Adult >= 60 years; Yes Pregnant women, adults with chronic diseases, elderly and other risk groups
Influenza_Pediatric 6 months to 8 years (x2) Yes
JE_Inactd 8 months; +7 days; 2, 6 years; Yes
JE_LiveAtd 8 months; 2 years; Yes
MMR 18-24 months; Yes
MR 8 months; Yes
MenA 6-18 months (x2); Yes polysaccharide
MenAC 3, 6 years; Yes
OPV 2, 3, 4 months; 4 years; Yes

Immunizaton indicators

Indicator Expected answer 2014  2013  2012  2011  2010  2009  2008 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2011-2015  2011-2015  2011-2015  2011-2015  2011-2015     
Nº of districts with microplans that include activities to raise immunization coverage number             2'859 

System performance

Total Nº districts in country number 2'959  2'959  2'956  3'092  3'092  3'118  3'105 
Nº districts with DTP3 coverage >=80% number 2'710  2'952  2'955  3'048  3'038  3'093  3'094 
% of districts with DTP3 coverage >=80% From 0 to 100% 92  100  100  99  98  99  100 
Nº districts with measles (MCV1) coverage >=95% number 2'345  2'917  2'913  3'002  2'983  2'812   
% of districts with MCV1 coverage >=95% From 0 to 100% 79  99  99  97  96  90   

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  Yes  Yes  Yes     
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Finance

Immunization expenditure financed, using Government funds? From 0 to 100% 100  100  100  100    100  100 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  Yes  Yes  Yes  Yes     

Sources

 1  "The 2015 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.